Back to search results

Improving Diagnosis for Anemia and Kidney Function

This study is testing a new team approach to help doctors better diagnose the causes of anemia (low red blood cell count) and decreased GFR (glomerular filtration rate, a measure of kidney function). This new approach, called "Enhanced diagnostic team," involves using automated tools to track abnormal test results, adding care coordinators to the primary care team, and using navigators to help patients. This is being compared to "Usual care," which is how doctors typically evaluate these conditions. The study wants to see if the new approach leads to more accurate diagnoses within 6 months. You might be able to join if you are 18 or older and have low hemoglobin (a protein in red blood cells) or decreased GFR. The study is currently unclear on its recruitment status and plans to enroll 450 people.

Study design
This is an interventional study comparing an enhanced diagnostic team approach to usual care. It plans to enroll 450 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The study will follow participants for 6 months from when they start to measure diagnosis accuracy.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05735314

A New Combination of Evidence-Based Interventions to Improve Primary Care Diagnostic Safety and Efficiency

Recruiting
NAAges 18+InterventionalHealth services
The University of Texas Health Science Center, Houston
~450 participants
Updated 2025-12-30 on ClinicalTrials.gov
What's tested:Enhanced diagnostic team implementing three evidence-based interventionsUsual care

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Percentage of subjects who have correct diagnosis of cause of low hemoglobin
Measured over within 6 months from baseline
+1 more outcome measured

Conditions

Anemia
Decreased Glomerular Filtration Rate

Explore related trials

AnemiaChronic Kidney Disease

Where it's being run

1 sites across 1 states
Texas1

Study leadership

  • Eric Thomas, MD,MPH · PRINCIPAL_INVESTIGATOR · The University of Texas Health Science Center, Houston

Who to contact

Eric Thomas, MD,MPH
[email protected]
713-500-7958
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

physicians, physicians assistants and advanced practice registered nurses in the 13 clinic locations of UTP are eligible if they care for patients at the time patient enrollment at their clinic begins
agree to participate.
hemoglobin result \< 10.8 for females and \< 12.5 for males with normal white cell count and platelet count (the prior hemoglobin results must have been in normal range, with a look-back period of two years)
an eGFR value \< 60 (the prior eGFR results must have been in normal range, with a look-back range of two years)
the matching creatinine results must also be in normal range
not pregnant
speak English or Spanish.

What this trial measures

  • Percentage of subjects who have correct diagnosis of cause of low hemoglobinwithin 6 months from baseline

    Percentage of subjects who have correct diagnosis of cause of low hemoglobin

  • Percentage of subjects who have correct diagnosis of cause of low glomerular filtrationwithin 6 months from baseline

    Percentage of subjects who have correct diagnosis of cause of low glomerular filtration